Nanosphere, Inc. (NSPH) - Product Pipeline Analysis by GlobalData

VIEWS: 32 PAGES: 40

Nanosphere, Inc. (NSPH) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Nanosphere, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons t

More Info
									                                      Nanosphere, Inc. (NSPH) - Product Pipeline Analysis

     Reference Code: GDMEPH8678PD                                                                                                Publication Date: NOV 2010



     Company Snapshot                                                         Company Overview
     Key Information
                                                                              Nanosphere, Inc. (Nanosphere) is a nanotechnology-based molecular
     Nanosphere, Inc., Key Facts                                              diagnostics company, offering proprietary breakthrough technologies that
                                                                              provide a unique and powerful solution to greatly simplify molecular
     Web Address                            www.nanosphere.us
                                                                              diagnostic testing. The company's Verigene System is a benchtop
     Turnover (in USD Million) 2.20                                           molecular diagnostics workstation that utilizes patented gold nanoparticle
                                                                              technology to detect nucleic acid and protein targets of interest in a variety
     Number of Employees                    116                               of applications. The company is headquartered in Northbrook, Illinois, the
     Industry                               Pharmaceuticals and Healthcare-   US.
     Source:Primary / Secondary Research
     GlobalData



     Nanosphere, Inc. Pipeline Products

      Nanosphere, Inc. Key Pipeline Products by Equipment                     Nanosphere, Inc. Key Pipeline Products by Therapy Area
      Type
     Equipment Type                         No of Products                    Therapy Area                                             No of Products
     Infectious Immunology                         2                          Respiratory tract infections                                    2
     Genetic Testing                               2                          Acute coronary syndrome, Myocardial infarction                   1
     Immuno Chemistry                                             1           Hemochromatosis                                                  1
     Source: Primary / Secondary Research                                     Source: Primary / Secondary Research
     GlobalData                                                               GlobalData


     Nanosphere, Inc. Key Pipeline Products by Equipment Type




     Source: Primary / Secondary Research
     GlobalData




     Nanosphere, Inc. Key Pipeline Products by                                Nanosphere, Inc. Key Pipeline Products by Trial Phase
     Development Stage
     Developmental Stage                No of Products                        Trial Phase                                      No of Products
     Clinicals                                 1                              Phase IV                                                 -
     Pre-Clinicals                                                            Phase III                                                1
                                               -
     Early development                                        2               Phase II                                                 -
     Source: Primary / Secondary Research                                     Phase I                                                  -
     GlobalData
                                                                              Source: Primary / Secondary Research
     Note : (-) indicates 'Not Available'
                                                                              GlobalData
                                                                              Note : (-) indicates 'Not Available'




Nanosphere, Inc. (NSPH) - Product Pipeline Analysis                                                                                 Reference Code: GDMEPH8678PD

Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 3
     Key Facts ............................................................................................................................................................................................................................................................................... 4
     Nanosphere, Inc. - Major Products and Services................................................................................................................................................................................................................... 5
           Nanosphere, Inc. Pipeline Products by Equipment Type ................................................................................................................................................................................................ 6
           Nanosphere, Inc. Pipeline Products by Development Stage ........................................................................................................................................................................................... 8
           Nanosphere, Inc. Pipeline Products by Therapy Area................................................................................................................................................................................................... 10
           Nanosphere, Inc. Pipeline Products by Trial Phase ...................................................................................................................................................................................................... 12
           Nanosphere, Inc. Pipeline Products by Milestone Summary......................................................................................................................................................................................... 14
           Expanded respiratory test.............................................................................................................................................................................................................................................. 16
                 Product Status......................................................................................................................................................................................................................................................... 16
                 Product Description ................................................................................................................................................................................................................................................. 16
           Expanded Respiratory Virus Panel Assay ..................................................................................................................................................................................................................... 16
                 Product Status......................................................................................................................................................................................................................................................... 16
                 Product Description ................................................................................................................................................................................................................................................. 16
           Verigene Cardiac Troponin I Assay ............................................................................................................................................................................................................................... 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
                 Product Milestone ................................................................................................................................................................................................................................................... 17
                 Verigene Cardiac Troponin I Assay Clinical Trial.................................................................................................................................................................................................... 17
           Verigene CYP2C19 Assay............................................................................................................................................................................................................................................. 19
                 Product Status......................................................................................................................................................................................................................................................... 19
                 Product Description ................................................................................................................................................................................................................................................. 19
           Verigene HFE Nucleic Acid Test ................................................................................................................................................................................................................................... 19
                 Product Status......................................................................................................................................................................................................................................................... 19
                 Product Description ................................................................................................................................................................................................................................................. 19
                 Product Patent Details ............................................................................................................................................................................................................................................ 20
     Nanosphere, Inc. - Key Competitors .................................................................................................................................................................................................................................... 33
     Nanosphere, Inc. - Key Employees...................................................................................................................................................................................................................................... 34
     Nanosphere, Inc. - Locations And Subsidiaries ................................................................................................................................................................................................................... 35
           Head Office.................................................................................................................................................................................................................................................................... 35
     Recent Developments.......................................................................................................................................................................................................................................................... 36
                 May 06, 2010: Nanosphere Reports Q1 2010 Results ................................................................................................................................................................................
								
To top